KR20100014858A - 국소 비강 투여용 올로파타딘 제제 - Google Patents

국소 비강 투여용 올로파타딘 제제 Download PDF

Info

Publication number
KR20100014858A
KR20100014858A KR1020097017832A KR20097017832A KR20100014858A KR 20100014858 A KR20100014858 A KR 20100014858A KR 1020097017832 A KR1020097017832 A KR 1020097017832A KR 20097017832 A KR20097017832 A KR 20097017832A KR 20100014858 A KR20100014858 A KR 20100014858A
Authority
KR
South Korea
Prior art keywords
olopatadine
composition
nacl
phosphate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097017832A
Other languages
English (en)
Korean (ko)
Inventor
온카 엔. 싱
지. 마이클 월
라지니 자니
마수드 에이. 초완
웨슬리 웨신 한
Original Assignee
알콘, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘, 인코퍼레이티드 filed Critical 알콘, 인코퍼레이티드
Publication of KR20100014858A publication Critical patent/KR20100014858A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020097017832A 2007-02-07 2007-02-07 국소 비강 투여용 올로파타딘 제제 Ceased KR20100014858A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/003285 WO2008097220A1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration

Publications (1)

Publication Number Publication Date
KR20100014858A true KR20100014858A (ko) 2010-02-11

Family

ID=38542957

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097017832A Ceased KR20100014858A (ko) 2007-02-07 2007-02-07 국소 비강 투여용 올로파타딘 제제

Country Status (15)

Country Link
EP (2) EP2114367B1 (https=)
JP (1) JP5149308B2 (https=)
KR (1) KR20100014858A (https=)
CN (1) CN101621989A (https=)
AU (1) AU2007346121B2 (https=)
BR (1) BRPI0721255B8 (https=)
CA (1) CA2677631C (https=)
DK (1) DK2114367T3 (https=)
ES (2) ES2557939T3 (https=)
HU (1) HUE026162T2 (https=)
MX (1) MX2009008548A (https=)
PL (1) PL2114367T3 (https=)
PT (1) PT2114367E (https=)
SI (1) SI2114367T1 (https=)
WO (1) WO2008097220A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
KR20140120932A (ko) * 2012-02-10 2014-10-14 알콘 리서치, 리미티드 증대된 안정성을 갖는 수성 약제학적 조성물

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
EP2453872B1 (en) * 2009-07-17 2013-08-21 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
CN103830219A (zh) * 2012-11-20 2014-06-04 深圳大佛药业有限公司 一种稳定的奥洛他定组合物
CN114980881A (zh) * 2019-12-06 2022-08-30 东兴药品工业株式会社 包含奥洛他定的鼻用组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
DE60109742T2 (de) * 2000-01-25 2005-08-18 Alcon Inc. Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
BR0316203A (pt) * 2002-11-12 2005-10-04 Alcon Inc Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
AU2005309951B2 (en) 2004-11-24 2011-07-07 Alcon, Inc. Method of delivering nasal spray

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
KR20140120932A (ko) * 2012-02-10 2014-10-14 알콘 리서치, 리미티드 증대된 안정성을 갖는 수성 약제학적 조성물

Also Published As

Publication number Publication date
EP2114367A1 (en) 2009-11-11
PL2114367T3 (pl) 2016-03-31
HUE026162T2 (en) 2016-05-30
SI2114367T1 (sl) 2016-01-29
EP2977042A1 (en) 2016-01-27
EP2977042B1 (en) 2020-01-01
PT2114367E (pt) 2016-02-01
BRPI0721255B1 (pt) 2019-08-27
CN101621989A (zh) 2010-01-06
WO2008097220A1 (en) 2008-08-14
ES2781090T3 (es) 2020-08-28
JP2010518075A (ja) 2010-05-27
MX2009008548A (es) 2009-08-18
HK1217090A1 (en) 2016-12-23
JP5149308B2 (ja) 2013-02-20
EP2114367B1 (en) 2015-11-04
AU2007346121B2 (en) 2012-08-23
BRPI0721255A2 (pt) 2013-01-01
AU2007346121A1 (en) 2008-08-14
CA2677631A1 (en) 2008-08-14
ES2557939T3 (es) 2016-01-29
CA2677631C (en) 2014-05-13
BRPI0721255B8 (pt) 2021-05-25
DK2114367T3 (en) 2015-12-07

Similar Documents

Publication Publication Date Title
US8399508B2 (en) Olopatadine formulations for topical nasal administration
EP2453872B1 (en) Olopatadine nasal spray regimen for children
JPWO2000010570A1 (ja) 水性液剤
AU5302699A (en) Aqueous liquid preparations
KR20100014858A (ko) 국소 비강 투여용 올로파타딘 제제
CN107073008A (zh) 眼科用水性组合物
ES2247372T3 (es) Composicion oftalmica que contiene n-acetilcisteina para el tratamiento del sindrome de ojos secos.
JPH01294620A (ja) 水溶液製剤およびその製造方法
CN104098491B (zh) 一种乙酰半胱氨酸化合物及含有该化合物的吸入用乙酰半胱氨酸溶液
ES2460967T3 (es) Método para la prevención de la degradación de una sustancia térmicamente inestable
JPH0611704B2 (ja) 角膜疾患治療用点眼剤
SA90110074B1 (ar) تركيبات صيدلانية متضمنة على محلول مائي من مشتق بيرانوكوينولين pyranoquinoline
HK1217090B (en) Olopatadine formulations for topical nasal administration
JPH08268892A (ja) 水溶液製剤及びその製造方法
CN112569211A (zh) 一种吸入用加替沙星溶液及其制备方法
CN102497854A (zh) 含有作为防腐剂的丙酸衍生物的眼用液体药物组合物
HK40048324A (en) A kind of gatifloxacin solution for inhalation and its preparation method
WO2025040941A1 (en) Ophthalmic pharmaceutical compositions containing dorzolamide, methods for their preparation, and for their use
CN111643448A (zh) 一种盐酸莫西沙星眼用凝胶剂及其制备方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090826

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120130

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130717

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20131028

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130717

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I